The Global Newborn Screening Market was valued at USD 1.05 Bn in the year 2023 and is expected to reach USD 1.75 Bn by 2030 with a growing CAGR of 7.54 % over the forecast period of 2024-2030.Newborn Screening Market Overview:
The newborn screening program is a vital sector of healthcare, which focuses on early detection and diagnosis of genetic, metabolic, and congenital disorders in infants. Newborn screening programs typically involve collecting blood, or tissue samples from newborns shortly after birth and analyzing them for markers of various diseases. The screening process varies by region and healthcare system but often targets disorders such as phenylketonuria (PKU), cystic fibrosis, congenital hypothyroidism, and sickle cell disease. The factors driving the newborn screening market include increasing birth rates globally, rising awareness about the benefits of early diagnosis, and advancements in screening technologies with technological innovations, such as TMS, next-generation sequencing (NGS), and molecular diagnostics, which have significantly enhanced the accuracy and scope of newborn screening. These technologies allow for the detection of disorders with improved specificity which supports early detection and personalized treatment options in infants. Many countries have established national or regional newborn screening programs, mandating specific screening tests for all newborns to ensure uniformity and consistency in healthcare sector. Hearing screening test, detects hearing impairments early is a prominent segment in the market supporting detection and diagnosis of hearing disorders. Some of the challenges in the newborn screening market are the high cost of advanced screening technologies, variability in screening protocols and guidelines across regions, and ethical considerations related to consent, and privacy of the patient information. The North America newborn screening market held the largest share in 2023 owing to standard healthcare infrastructure, research facilities and government bodies like CDC, AAP, HRSA, GARD and ACHDNC that mandate newborn screening test after the birth of infants. In US, 4 million babies are screened annually of which more than 12,500 are found to have severe disorders that are left untreated and 31 cases of serious disorders. The partnerships between healthcare providers, screening laboratories, and regulatory bodies are essential for driving innovation, expanding market reach, and enhancing the effectiveness of newborn screening programs. Overall, the newborn screening market is evolving with a market potential of 1.75 Bn over the forecast period along with advancements in technology, healthcare infrastructure, and increasing global awareness. These factors collectively contribute to the growth and development of newborn screening platforms worldwide, with highlighting its critical role in early detection of diseases and improved health outcomes.To know about the Research Methodology:-Request Free Sample Report
Newborn Screening Market Dynamics:
Increasing birth rate and population growth are driving the newborn screening market: The increasing number of births worldwide directly affects the demand for newborn screening tests as government of many countries have mandated newborn screening programs, which boost the market growth by increasing the number of tests performed. The innovations in screening technologies, such as tandem mass spectrometry (MS/MS) and next-generation sequencing (NGS), enhance the accuracy of newborn screening, thereby driving the newborn market growth. The growing awareness about the benefits of early detection of congenital disorders and genetic diseases drives the adoption of newborn screening tests. Developments in genetic research and in the field of genomics contribute to the expanding range of conditions that are screened in newborns at early stage. The improvements in healthcare infrastructure have lead to increased access to newborn screening services. The increasing number of genetic disorders and chronic diseases among newborns has necessitated the early detection in newborn, thereby driving the demand for newborn screening market. The integration of newborn screening technologies with other diagnostic systems facilitates the processes and enhances market growth. According to Indian Pediatric Academy, occurrence of congenital heart disease in children is high and every year more than 200000 children are born with congenital heart disease. The cost of screening and awareness among the population are the newborn screening market restraints: The high cost associated with advanced screening technologies, such as next-generation sequencing (NGS) and tandem mass spectrometry limits the accessibility, particularly in remote regions with constrained healthcare budgets. The lack of awareness among healthcare providers, parents, and caregivers about the importance of newborn screening and the availability of screening programs results in low number of screening rates, delaying diagnosis and intervention for infants with genetic disorders. Certain ethical concerns related to consent for screening, storage of genetic information, and the implications of false results impose challenges to the adoption and acceptance of newborn screening programs. The inadequate healthcare infrastructure and limited availability of trained personnel, especially in rural areas, affects the implementation and expansion of screening programs. Opportunities in the newborn screening market: The expansion of test panels is creating an opportunity to expand the range of conditions screened in newborns apart from the traditional metabolic disorders. The advances in genetic testing and genomics allow for the inclusion of more rare genetic conditions and diseases, that provide broad screening panels. The continuous advancements in newborn screening technologies, such as next-generation sequencing (NGS), microarray analysis, and digital PCR, hold opportunities to improve the accuracy and speed of newborn screening tests. These technologies enable more precise diagnosis and early intervention of any disease occurring in a newborn. The development of point-of-care testing (POCT) devices for newborn screening offers opportunities to simplify the screening process, reduce turnaround times, and improve the accessibility of screening tests in resource-limited and remote areas. According to UN Children Fund, India records 21 million births every year and this high birth rate demands for newborn screening tools and tests availability across public and private hospitals and childcare centres.
Newborn Screening Market Segmentation:
Based on test, the dry blood spot test type of segment has the largest market share of newborn screening market over the forecast period as there are product launches for the screening of dry blood spot tests. The dry blood spot test kits are used for more than 40+ conditions associated with newborn screening. The initiatives taken by government authorities to promote blood tests are boosting the growth of the segment. The hearing segment also holds a significant market share as hearing screening test is a critical component of newborn screening programs worldwide healthcare guidelines in many countries. Early detection of hearing loss does timely intervention and diagnosis, which improves the outcomes in infants. The prominence of the hearing screening segment highlights its essential role in newborn care and the overall newborn screening market. Based on end user, the hospital segment is expected to dominate the newborn screening market over the forecast period. These healthcare facilities are at the primary places of newborn screening programs, where screening tests are routinely conducted after birth. Hospitals play a vital role in implementing screening protocols, collecting samples, conducting tests, interpreting results, and initiating the diagnostic interventions as required. They serve as the primary point of care for newborns and their families, ensuring that screening results are communicated effectively and appropriate follow-up care is provided. Healthcare providers in hospitals and clinics collaborate with laboratories and screening centres to ensure the integration of newborn screening into routine healthcare practices, thereby contributing significantly to the adoption and expansion of newborn screening programs.
Newborn Screening Market, Regional Insights:
The North America newborn screening market held the largest market share in 2023 which is attributed to factors such as well-established healthcare infrastructure, awareness about the benefits of newborn screening, government initiatives mandating screening programs, and the presence of advanced healthcare technologies and research facilities. The United States is the largest market for newborn screening, which accounts for a significant portion of the region's market share. The U.S. has a robust healthcare system with broad newborn screening programs that cover a range of genetic disorders and other conditions. There is also a strong emphasis on early detection and diagnosis, which is supported by funding agencies for newborn screening initiatives. According to NIH, 4 million infants are born each year in US, and 25-30% of them undergo newborn screening process and other states report show participation upto 95% in newborn screening test. Other regions, such as Europe and Asia-Pacific, contribute significantly to the global newborn screening market. The European countries like Germany, France, and the UK have well-established screening programs, although the market scenario varies by country due to differences in healthcare policies. In Asia-Pacific, countries such as China, Japan, and India are expanding their newborn screening centres, which is driven by increasing healthcare expenditure, rising awareness, and improving the existing healthcare infrastructure. India and China being the two most populated countries within Asia-Pacific are driving the growth of the market in the region. Contributions of regulatory bodies for newborn screening test: 1. The Texas Department of Health and Human Services began its Newborn Screening Program (NBS) in 2021 for detection of Spinal Muscular Atrophy (SMA). SMA is a rare neuromuscular disorder that results in the loss of motor neurons and progressive muscle wasting and is among the leading genetic causes of death in infants and toddlers. 2. The American Academy of Pediatrics (AAP) has strongly recommended newborn screening as the best way to detect a health problem at an early stage that can cause serious lifelong disabilities and, in some cases, end a child's life. More than 50 states of US have adopted the screening programs under the guideline from AAP. Competitive Landscape of Newborn Screening Market: The competitive landscape of the newborn screening market is characterized by a presence of market players including healthcare providers, diagnostic laboratories, and regulatory bodies. Key participants in this market include major diagnostic companies like PerkinElmer, Bio-Rad Laboratories, and GE Healthcare, which offer a range of screening tests and technologies. These companies focus on enhancing the sensitivity, and throughput of screening assays, often leveraging advanced technologies such as TMS, next-generation sequencing (NGS), and molecular diagnostics. There is significant competition among technology providers in developing innovative point-of-care testing (POCT) solutions that aim at improving accessibility of screening results. Regulatory bodies play a role in modifying the competitive landscape by setting guidelines and standards for newborn screening protocols and approving new screening tests. Collaborations and partnerships between industries and healthcare providers are common strategies to drive innovation and expand market reach in the evolving healthcare sector and increasing demand for comprehensive newborn screening solutions globally. 1. In 2020, PerkinElmer (US) received CE-IVD approval for EONIS screening assay which is used to screen for spinal muscular atrophy (SMA), and XLA (X-linked agammaglobulinemia) in newborns. 2. In 2020, a group of leading rare disease focused organizations, including EveryLife Foundation for rare diseases, Sarepta Therapeutics and Retrophin announced its join effort to evaluate the capacity of newborn screening in US in order to provide timely diagnosis of all newborns. 3. In 2019, PerkinElmer (US) received US FDA approval for GSP Neonatal Creatine Kinase MM (CK-MM) kit for screening newborns affected by Duchenne muscular dystrophy.Newborn Screening Market Scope: Inquire before buying
Newborn Screening Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 1.05 Bn. Forecast Period 2024 to 2030 CAGR: 7.54 % Market Size in 2030: US $ 1.75 Bn. Segments Covered: by Product Type Instruments Consumables Others by Test Type Dry blood spot test Hearing screening test Heart screening test Others by Technology Tandem Mass Spectroscopy (TMS) Immunoassays Hearing screening technology Others by Test Type Hospitals Clinical Laboratories Newborn Screening Market, by Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key Players Operating In Newborn Screening Market:
1. PerkinElmer (US) 2. Bio-Rad Laboratories (US) 3. GE Healthcare (Germany) 4. Agilent Technologies (US) 5. Thermo Fisher Scientific (US) 6. Waters Corporation (US) 7. Trivitron Healthcare (India) 8. Natus Medical Incorporated (US) 9. Baebies, Inc. (US) 10. Danaher Corporation (US) 11. Medtronic plc (Ireland) 12. Parseq Labs (Czech Republic) Frequently Asked Questions FAQ’s 1] What segments are covered in Global Newborn Screening report? Ans. The segments covered in Global Newborn Screening report are based on Product type, Test type, Technology and End User. 2] Which region held the largest Newborn Screening share in 2023? Ans. North America is expected to hold the largest Newborn Screening share in 2023. 3] Who are the top players in the Global Newborn Screening Market? Ans. PerkinElmer, Baebies, Thermo Fischer Scientific, Agilent Technologies, are the top players in the Global Newborn Screening Market. 4] What is the expected Global Newborn Screening size by 2030? Ans. The expected Global Newborn Screening size is USD 1.75 Bn by 2030. 5] What was the Global Newborn Screening size in 2023? Ans. The Global Newborn Screening size was worth USD 1.05 Bn in 2023.
1. Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Product Segment 2.3.3. End-user Segment 2.3.4. Revenue (2023) 2.4. Leading Newborn Screening Market Companies, by Market Capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Newborn Screening Market: Dynamics 3.1. Newborn Screening Market Trends by Region 3.1.1. North America Newborn Screening Market Trends 3.1.2. Europe Newborn Screening Market Trends 3.1.3. Asia Pacific Newborn Screening Market Trends 3.1.4. Middle East and Africa Market Trends 3.1.5. South America Newborn Screening Market Trends 3.2. Newborn Screening Market Dynamics by Global 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Value Chain Analysis 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Analysis of Government Schemes and Initiatives for the Newborn Screening Industry 4. Newborn Screening Market: Global Market Size and Forecast by Segmentation (by Value USD Mn) (2024-2030) 4.1. Newborn Screening Market Size and Forecast, By Product Type (2024-2030) 4.1.1. Instruments 4.1.2. Consumables 4.1.3. Others 4.2. Newborn Screening Market Size and Forecast, By Test type (2024-2030) 4.2.1. Dry Blood Spot Test 4.2.2. Hearing Screening Test 4.2.3. Heart Screening Test 4.2.4. Others 4.3. Newborn Screening Market Size and Forecast, By Technology (2024-2030) 4.3.1. Tandem Mass Spectroscopy 4.3.2. Immunoassays 4.3.3. Hearing Screening Technology 4.3.4. Others 4.4. Newborn Screening Market Size and Forecast, By End User (2024-2030) 4.4.1. Hospitals 4.4.2. Clinical Laboratories 4.5. Newborn Screening Market Size and Forecast, by Region (2023-2030) 4.5.1. North America 4.5.2. Europe 4.5.3. Asia Pacific 4.5.4. Middle East and Africa 4.5.5. South America 5. North America Newborn Screening Market Size and Forecast by Segmentation (by Value USD Mn) (2024-2030) 5.1. North America Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 5.1.1. Instruments 5.1.2. Consumables 5.1.3. Others 5.2. North America Newborn Screening Market Size and Forecast, By Test type(2024-2030) 5.2.1. Dry Blood Spot Test 5.2.2. Hearing Screening Test 5.2.3. Heart Screening Test 5.2.4. Others 5.3. Newborn Screening Market Size and Forecast, By Technology (2024-2030) 5.3.1. Tandem Mass Spectroscopy 5.3.2. Immunoassays 5.3.3. Hearing Screening Technology 5.3.4. Others 5.4. Newborn Screening Market Size and Forecast, By End User(2024-2030) 5.4.1. Hospitals 5.4.2. Clinical Laboratories 5.5. North America Newborn Screening Market Size and Forecast, by Country (2024-2030) 5.5.1. United States 5.5.1.1. United States Newborn Screening Market Size and Forecast, By Product Type (2024-2030) 5.5.1.1.1. Instruments 5.5.1.1.2. Consumables 5.5.1.1.3. Others 5.5.1.2. United States Newborn Screening Market Size and Forecast, By Test type(2024-2030) 5.5.1.2.1. Dry Blood Spot Test 5.5.1.2.2. Hearing Screening Test 5.5.1.2.3. Heart Screening Test 5.5.1.2.4. Others 5.5.1.3. United States Newborn Screening Market Size and Forecast, By Technology (2024-2030) 5.5.1.3.1. Tandem Mass Spectroscopy 5.5.1.3.2. Immunoassays 5.5.1.3.3. Hearing Screening Technology 5.5.1.3.4. Others 5.5.1.4. United States Newborn Screening Market Size and Forecast, By End User (2024-2030) 5.5.1.4.1. Hospitals 5.5.1.4.2. Clinical Laboratories 5.5.2. Canada 5.5.2.1. Canada Newborn Screening Market Size and Forecast, By Product Type 5.5.2.1.1. Instruments 5.5.2.1.2. Consumables 5.5.2.1.3. Others 5.5.2.2. Canada Newborn Screening Market Size and Forecast, By Test type(2024-2030) 5.5.2.2.1. Dry Blood Spot Test 5.5.2.2.2. Hearing Screening Test 5.5.2.2.3. Heart Screening Test 5.5.2.2.4. Others 5.5.2.3. Canada Newborn Screening Market Size and Forecast, By Technology (2024-2030) 5.5.2.3.1. Tandem Mass Spectroscopy 5.5.2.3.2. Immunoassays 5.5.2.3.3. Hearing Screening Technology 5.5.2.3.4. Others 5.5.2.4. Canada Newborn Screening Market Size and Forecast, By End User(2024-2030) 5.5.2.4.1. Hospitals 5.5.2.4.2. Clinical Laboratories 5.5.3. Mexico 5.5.3.1. Mexico Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 5.5.3.1.1. Instruments 5.5.3.1.2. Consumables 5.5.3.1.3. Others 5.5.3.2. Mexico Newborn Screening Market Size and Forecast, By Test type(2024-2030) 5.5.3.2.1. Dry Blood Spot Test 5.5.3.2.2. Hearing Screening Test 5.5.3.2.3. Heart Screening Test 5.5.3.2.4. Others 5.5.3.3. Mexico Newborn Screening Market Size and Forecast, By Technology (2024-2030) 5.5.3.3.1. Tandem Mass Spectroscopy 5.5.3.3.2. Immunoassays 5.5.3.3.3. Hearing Screening Technology 5.5.3.3.4. Others 5.5.3.4. Mexico Newborn Screening Market Size and Forecast, By End User(2024-2030) 5.5.3.4.1. Hospitals 5.5.3.4.2. Clinical Laboratories 6. Europe Newborn Screening Market Size and Forecast by Segmentation (by Value USD Mn) (2024-2030) 6.1. Europe Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 6.2. Europe Newborn Screening Market Size and Forecast, By Test type(2024-2030) 6.3. Europe Newborn Screening Market Size and Forecast, By Technology (2024-2030) 6.4. Europe Newborn Screening Market Size and Forecast, By End User(2024-2030) 6.5. Europe Newborn Screening Market Size and Forecast, by Country (2024-2030) 6.5.1. United Kingdom 6.5.1.1. United Kingdom Newborn Screening Market Size and Forecast, By Product Type (2024-2030) 6.5.1.2. United Kingdom Newborn Screening Market Size and Forecast, By Test type(2024-2030) 6.5.1.3. United Kingdom Newborn Screening Market Size and Forecast, By Technology (2024-2030) 6.5.1.4. United Kingdom Newborn Screening Market Size and Forecast, By End User(2024-2030) 6.5.2. France 6.5.2.1. France Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 6.5.2.2. France Newborn Screening Market Size and Forecast, By Test type(2024-2030) 6.5.2.3. France Newborn Screening Market Size and Forecast, By Technology (2024-2030) 6.5.2.4. France Newborn Screening Market Size and Forecast, By End User(2024-2030) 6.5.3. Germany 6.5.3.1. Germany Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 6.5.3.2. Germany Newborn Screening Market Size and Forecast, By Test type(2024-2030) 6.5.3.3. Germany Newborn Screening Market Size and Forecast, By Technology (2024-2030) 6.5.3.4. Germany Newborn Screening Market Size and Forecast, By End User(2024-2030) 6.5.4. Italy 6.5.4.1. Italy Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 6.5.4.2. Italy Newborn Screening Market Size and Forecast, By Test type(2024-2030) 6.5.4.3. Italy Newborn Screening Market Size and Forecast, By Technology (2024-2030) 6.5.4.4. Italy Newborn Screening Market Size and Forecast, By End User(2024-2030) 6.5.5. Spain 6.5.5.1. Spain Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 6.5.5.2. Spain Newborn Screening Market Size and Forecast, By Test type(2024-2030) 6.5.5.3. Spain Newborn Screening Market Size and Forecast, By Technology (2024-2030) 6.5.5.4. Spain Newborn Screening Market Size and Forecast, By End User(2024-2030) 6.5.6. Sweden 6.5.6.1. Sweden Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 6.5.6.2. Sweden Newborn Screening Market Size and Forecast, By Test type(2024-2030) 6.5.6.3. Sweden Newborn Screening Market Size and Forecast, By Technology (2024-2030) 6.5.6.4. Sweden Newborn Screening Market Size and Forecast, By End User(2024-2030) 6.5.7. Austria 6.5.7.1. Austria Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 6.5.7.2. Austria Newborn Screening Market Size and Forecast, By Test type(2024-2030) 6.5.7.3. Austria Newborn Screening Market Size and Forecast, By Technology (2024-2030) 6.5.7.4. Austria Newborn Screening Market Size and Forecast, By End User(2024-2030) 6.5.8. Rest of Europe 6.5.8.1. Rest of Europe Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 6.5.8.2. Rest of Europe Newborn Screening Market Size and Forecast, By Test type(2024-2030) 6.5.8.3. Rest of Europe Newborn Screening Market Size and Forecast, By Technology (2024-2030) 6.5.8.4. Rest of Europe Newborn Screening Market Size and Forecast, By End User(2024-2030) 7. Asia Pacific Newborn Screening Market Size and Forecast by Segmentation (by Value USD Mn) (2024-2030) 7.1. Asia Pacific Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 7.2. Asia Pacific Newborn Screening Market Size and Forecast, By Test type (2024-2030) 7.3. Asia Pacific Newborn Screening Market Size and Forecast, By Technology (2024-2030) 7.4. Asia Pacific Newborn Screening Market Size and Forecast, By End User (2024-2030) 7.5. Asia Pacific Newborn Screening Market Size and Forecast, by Country (2024-2030) 7.5.1. China 7.5.1.1. China Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 7.5.1.2. China Newborn Screening Market Size and Forecast, By Test type(2024-2030) 7.5.1.3. China Newborn Screening Market Size and Forecast, By Technology (2024-2030) 7.5.1.4. China Newborn Screening Market Size and Forecast, By End User (2024-2030) 7.5.2. S Korea 7.5.2.1. S Korea Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 7.5.2.2. S Korea Newborn Screening Market Size and Forecast, By Test type(2024-2030) 7.5.2.3. S Korea Newborn Screening Market Size and Forecast, By Technology (2024-2030) 7.5.2.4. S Korea Newborn Screening Market Size and Forecast, By End User(2024-2030) 7.5.3. Japan 7.5.3.1. Japan Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 7.5.3.2. Japan Newborn Screening Market Size and Forecast, By Test type(2024-2030) 7.5.3.3. Japan Newborn Screening Market Size and Forecast, By Technology (2024-2030) 7.5.3.4. Japan Newborn Screening Market Size and Forecast, By End User(2024-2030) 7.5.4. India 7.5.4.1. India Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 7.5.4.2. India Newborn Screening Market Size and Forecast, By Test type(2024-2030) 7.5.4.3. India Newborn Screening Market Size and Forecast, By Technology (2024-2030) 7.5.4.4. India Newborn Screening Market Size and Forecast, By End User(2024-2030) 7.5.5. Australia 7.5.5.1. Australia Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 7.5.5.2. Australia Newborn Screening Market Size and Forecast, By Test type(2024-2030) 7.5.5.3. Australia Newborn Screening Market Size and Forecast, By Technology (2024-2030) 7.5.5.4. Australia Newborn Screening Market Size and Forecast, By End User(2024-2030) 7.5.6. Indonesia 7.5.6.1. Indonesia Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 7.5.6.2. Indonesia Newborn Screening Market Size and Forecast, By Test type(2024-2030) 7.5.6.3. Indonesia Newborn Screening Market Size and Forecast, By Technology (2024-2030) 7.5.6.4. Indonesia Newborn Screening Market Size and Forecast, By End User(2024-2030) 7.5.7. Malaysia 7.5.7.1. Malaysia Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 7.5.7.2. Malaysia Newborn Screening Market Size and Forecast, By Test type(2024-2030) 7.5.7.3. Malaysia Newborn Screening Market Size and Forecast, By Technology (2024-2030) 7.5.7.4. Malaysia Newborn Screening Market Size and Forecast, By End User(2024-2030) 7.5.8. Vietnam 7.5.8.1. Vietnam Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 7.5.8.2. Vietnam Newborn Screening Market Size and Forecast, By Test type(2024-2030) 7.5.8.3. Vietnam Newborn Screening Market Size and Forecast, By Technology (2024-2030) 7.5.8.4. Vietnam Newborn Screening Market Size and Forecast, By End User(2024-2030) 7.5.9. Taiwan 7.5.9.1. Taiwan Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 7.5.9.2. Taiwan Newborn Screening Market Size and Forecast, By Test type(2024-2030) 7.5.9.3. Taiwan Newborn Screening Market Size and Forecast, By Technology (2024-2030) 7.5.9.4. Taiwan Newborn Screening Market Size and Forecast, By End User(2024-2030) 7.5.10. Rest of Asia Pacific 7.5.10.1. Rest of Asia Pacific Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 7.5.10.2. Rest of Asia Pacific Newborn Screening Market Size and Forecast, By Test type(2024-2030) 7.5.10.3. Rest of Asia Newborn Screening Market Size and Forecast, By Technology (2024-2030) 7.5.10.4. Rest of Asia Pacific Newborn Screening Market Size and Forecast, By End User(2024-2030) 8. Middle East and Africa Newborn Screening Market Size and Forecast by Segmentation (by Value USD Mn) (2024-2030) 8.1. Middle East and Africa Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 8.2. Middle East and Africa Newborn Screening Market Size and Forecast, By Test type(2024-2030) 8.3. Middle East and Africa Newborn Screening Market Size and Forecast, By Technology (2024-2030) 8.4. Middle East and Africa Newborn Screening Market Size and Forecast, By End User(2024-2030) 8.5. Middle East and Africa Newborn Screening Market Size and Forecast, by Country (2024-2030) 8.5.1. South Africa 8.5.1.1. South Africa Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 8.5.1.2. South Africa Newborn Screening Market Size and Forecast, By Test type(2024-2030) 8.5.1.3. South Africa Newborn Screening Market Size and Forecast, By Technology (2024-2030) 8.5.1.4. South Africa Newborn Screening Market Size and Forecast, By End User(2024-2030) 8.5.2. GCC 8.5.2.1. GCC Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 8.5.2.2. GCC Newborn Screening Market Size and Forecast, By Test type(2024-2030) 8.5.2.3. GCC Newborn Screening Market Size and Forecast, By Technology (2024-2030) 8.5.2.4. GCC Newborn Screening Market Size and Forecast, By End User(2024-2030) 8.5.3. Nigeria 8.5.3.1. Nigeria Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 8.5.3.2. Nigeria Newborn Screening Market Size and Forecast, By Test type(2024-2030) 8.5.3.3. Nigeria Newborn Screening Market Size and Forecast, By Technology (2024-2030) 8.5.3.4. Nigeria Newborn Screening Market Size and Forecast, By End User(2024-2030) 8.5.4. Rest of ME&A 8.5.4.1. Rest of ME&A Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 8.5.4.2. Rest of ME&A Newborn Screening Market Size and Forecast, By Test type(2024-2030) 8.5.4.3. Rest of ME&A Newborn Screening Market Size and Forecast, By Technology (2024-2030) 8.5.4.4. Rest of ME&A Newborn Screening Market Size and Forecast, By End User(2024-2030) 9. South America Newborn Screening Market Size and Forecast by Segmentation (by Value USD Mn.)(2024-2030) 9.1. South America Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 9.2. South America Newborn Screening Market Size and Forecast, By Test type(2024-2030) 9.3. South America Newborn Screening Market Size and Forecast, By Technology (2024-2030) 9.4. South America Newborn Screening Market Size and Forecast, By End User(2024-2030) 9.5. South America Newborn Screening Market Size and Forecast, by Country (2024-2030) 9.5.1. Brazil 9.5.1.1. Brazil Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 9.5.1.2. Brazil Newborn Screening Market Size and Forecast, By Test type(2024-2030) 9.5.1.3. Brazil Newborn Screening Market Size and Forecast, By Technology (2024-2030) 9.5.1.4. Brazil Newborn Screening Market Size and Forecast, By End User(2024-2030) 9.5.2. Argentina 9.5.2.1. Argentina Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 9.5.2.2. Argentina Newborn Screening Market Size and Forecast, By Test type(2024-2030) 9.5.2.3. Argentina Newborn Screening Market Size and Forecast, By Technology (2024-2030) 9.5.2.4. Argentina Newborn Screening Market Size and Forecast, By End User(2024-2030) 9.5.3. Rest Of South America 9.5.3.1. Rest Of South America Newborn Screening Market Size and Forecast, By Product Type(2024-2030) 9.5.3.2. Rest Of South America Newborn Screening Market Size and Forecast, By Test type(2024-2030) 9.5.3.3. Rest Of South America Newborn Screening Market Size and Forecast, By Technology (2024-2030) 9.5.3.4. Rest Of South America Newborn Screening Market Size and Forecast, By End User(2024-2030) 10. Company Profile: Key Players 10.1. PerkinElmer 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. Bio-Rad Laboratories 10.3. GE Healthcare 10.4. Agilent Technologies 10.5. Thermo Fisher Scientific 10.6. Waters Corporation 10.7. Trivitron Healthcare 10.8. Natus Medical Incorporated 10.9. Baebies 10.10. Bio-Rad Laboratories, Inc. 10.11. Danaher Corporation 10.12. Medtronic 11. Key Findings & Analyst Recommendations 12. Newborn Screening Market: Research Methodology
